Related Experiment Video

Updated: May 27, 2026

Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique
08:11

Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique

Published on: November 11, 2022

K+ channels in the heart: new insights and therapeutic implications

Andrew Tinker1, Stephen C Harmer

  • 1BHF Laboratories and Department of Medicine, University College London, 5 University Street, London, UK. a.tinker@ucl.ac.uk

Expert Review of Clinical Pharmacology
|November 25, 2011
PubMed

Insights

Potassium channels regulate heart rhythm, but drugs targeting them can cause side effects. New research focuses on atrial-selective potassium channel blockers to treat abnormal heart rhythms without causing proarrhythmia.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Pharmacology

Background:

  • Potassium (K+) channels are crucial for cardiac action potentials and regulating heart rhythm.
  • Existing K+ channel blockers have shown limited success in treating ventricular arrhythmias due to proarrhythmia and side effects.
  • Current therapeutic strategies face challenges with broad K+ channel inhibition.

Purpose of the Study:

  • To explore the therapeutic potential of targeting specific K+ channels for treating abnormal heart rhythms.
  • To investigate atrial-selective K+ channel blockers as a strategy to mitigate proarrhythmic risks.
  • To evaluate drugs targeting I(Kur) (K(v)1.5) and I(KACh) (Kir3.1/3.4) for atrial fibrillation treatment.

Main Methods:

  • Review of existing literature on K+ channel function in cardiac electrophysiology.
  • Analysis of drug development strategies for K+ channel modulators.
  • Examination of the expression patterns of K+ channels in cardiac atria versus ventricles.

Main Results:

  • K+ channels significantly influence cardiac action potential and rhythm.
  • Ventricular K+ channel blockade has been associated with disappointing outcomes and proarrhythmia.
  • Atrial fibrillation treatments may benefit from drugs targeting atrial-specific K+ channels.
  • I(Kur) and I(KACh) channels are key targets for atrial-selective therapies.

Conclusions:

  • Targeting atrial-selective K+ channels offers a promising approach to treat supraventricular arrhythmias like atrial fibrillation.
  • This strategy aims to minimize the proarrhythmic side effects associated with non-selective K+ channel blockers.
  • Development of drugs targeting I(Kur) and I(KACh) is ongoing and holds therapeutic potential.

More Related Videos

Recording of Inward Rectifying K+ Currents in Freshly Isolated Basilar Artery Smooth Muscle Cells by Patch Clamp Technique07:19

Recording of Inward Rectifying K+ Currents in Freshly Isolated Basilar Artery Smooth Muscle Cells by Patch Clamp Technique

Published on: February 7, 2025

Determination of the Relative Cell Surface and Total Expression of Recombinant Ion Channels Using Flow Cytometry11:32

Determination of the Relative Cell Surface and Total Expression of Recombinant Ion Channels Using Flow Cytometry

Published on: September 28, 2016

Related Concept Videos

Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Non-gated Ion Channels01:24

Non-gated Ion Channels

Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
Non-gated Ion Channels01:24

Non-gated Ion Channels

Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...